GlobalData on MSN11h
EMA’s CHMP to approve BMS’ Opdivo for colorectal cancerThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a ...
Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of ...
This ultimately allowed it to reduce net debt by $4 billion in the quarter as well as ease investor concerns about the loss ...
Bristol Myers (BMY) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has recommended approval of Opdivo plus Yervoy for the ...
These six high-yield dividend stocks are universally loved by investment professionals and they now offer reasonable entry ...
1d
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY – Research Report) ...
Medpage Today on MSN4d
Targeted Combination Shows Promise in Metastatic Kidney CancerLOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...
We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...
Medpage Today on MSN6d
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease ControlThe study added to a limited database about the effects of perioperative IO combinations, which have emerged as standard of ...
Aethlon Medical reaches key milestone with enrollment of first patient in its Hemopurifier cancer trial in Australia: San Diego Wednesday, November 13, 2024, 15:30 Hrs [IST] Aethl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback